Home  »  Science   »  EQRx Inc. (NASDAQ:EQRX) Stock Has Fallen -32.40% Y...

EQRx Inc. (NASDAQ:EQRX) Stock Has Fallen -32.40% YTD, What Do Analysts Anticipate Next?

In last trading session, EQRx Inc. (NASDAQ:EQRX) saw 1.82 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $4.61 trading at -$0.24 or -4.95% at ring of the bell on the day assigns it a market valuation of $2.43B. That closing price of EQRX’s stock is at a discount of -116.7% from its 52-week high price of $9.99 and is indicating a premium of 42.95% from its 52-week low price of $2.63. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.2 million shares which gives us an average trading volume of 2.85 million if we extend that period to 3-months.

For EQRx Inc. (EQRX), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.19 in the current quarter.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored

EQRx Inc. (NASDAQ:EQRX) trade information

Upright in the red during last session for losing -4.95%, in the last five days EQRX remained trading in the red while hitting it’s week-highest on Thursday, 09/15/22 when the stock touched $4.61 price level, adding 13.02% to its value on the day. EQRx Inc.’s shares saw a change of -32.40% in year-to-date performance and have moved -14.31% in past 5-day. EQRx Inc. (NASDAQ:EQRX) showed a performance of -15.72% in past 30-days. Number of shares sold short was 20.72 million shares which calculate 5.59 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $7.13 to the stock, which implies a rise of 35.34% to its current value. Analysts have been projecting $5.50 as a low price target for the stock while placing it at a high target of $8.00. It follows that stock’s current price would drop -73.54% in reaching the projected high whereas dropping to the targeted low would mean a loss of -19.31% for stock’s current value.

EQRx Inc. (EQRX) estimates and forecasts

Statistics highlight that EQRx Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company added 16.12% of value to its shares in past 6 months, showing an annual growth rate of -93.55% while that of industry is 11.70. Apart from that, the company came lowering its revenue forecast for fiscal year 2022.

EQRX Dividends

EQRx Inc. is more likely to be releasing its next quarterly report in October and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

EQRx Inc. (NASDAQ:EQRX)’s Major holders

Insiders are in possession of 16.37% of company’s total shares while institution are holding 56.58 percent of that, with stock having share float percentage of 67.66%. Investors also watch the number of corporate investors in a company very closely, which is 56.58% institutions for EQRx Inc. that are currently holding shares of the company. SB Management Ltd is the top institutional holder at EQRX for having 43.18 million shares of worth $178.32 million. And as of Mar 30, 2022, it was holding 8.85% of the company’s outstanding shares.

The second largest institutional holder is Casdin Capital, LLC, which was holding about 39.53 million shares on Mar 30, 2022. The number of shares represents firm’s hold over 8.11% of outstanding shares, having a total worth of $163.25 million.

On the other hand, Fidelity Growth Company Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF are the top two Mutual Funds which own company’s shares. As of May 30, 2022, the former fund manager was holding 6.8 million shares of worth $37.84 million or 1.40% of the total outstanding shares. The later fund manager was in possession of 3.57 million shares on Jun 29, 2022, making its stake of worth around $16.73 million in the company or a holder of 0.73% of company’s stock.

Leave a Comment

Your email address will not be published.

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]